Research location
Kursk
Russia
Advertisement
Research activity in Kursk
RussiaCureCurrent currently publishes aggregate city-level research activity for this location: 112 trials and 113 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Kursk
112 linked trials · page 1 of 3A Study of Botensilimab and Balstilimab for the Treatment of Colorectal CancerNCT05608044 · 2022-11-30 · 1 site observation
ACTIVE_NOT_RECRUITING
A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Weekly Insulin IcodecNCT05352815 · 2022-06-01 · 1 site observation
COMPLETED
Study of Pemetrexed+Platinum Chemotherapy With or Without Cosibelimab in First Line Metastatic Non-squamous NSCLCNCT04786964 · 2021-12-08 · 1 site observation
TERMINATED
Study to Evaluate the Efficacy, Safety, and Tolerability of IMU-838 in Patients With Relapsing Multiple SclerosisNCT05134441 · 2021-11-18 · 1 site observation
ACTIVE_NOT_RECRUITING
A Research Study to Compare Two Types of Insulin, a New Weekly Insulin, Insulin Icodec and an Available Daily Insulin, Insulin Glargine, Both in Combination With Mealtime Insulin, in People With Type 2 Diabetes Who Use Daily Insulin and Mealtime Insulin (ONWARDS 4)NCT04880850 · 2021-05-14 · 1 site observation
COMPLETED
Study of DS-1062a Versus Docetaxel in Previously Treated Advanced or Metastatic Non-small Cell Lung Cancer With or Without Actionable Genomic Alterations (TROPION-LUNG01)NCT04656652 · 2020-12-21 · 1 site observation
ACTIVE_NOT_RECRUITING
Heart Failure Patients RegistryNCT04709263 · 2020-12-21 · 1 site observation
COMPLETED
Platinum-Based Chemotherapy With/Without INCMGA00012, an Anti-PD-1 Antibody, in Non-Small Cell Lung CancerNCT04205812 · 2020-09-11 · 1 site observation
COMPLETED
A Study to Investigate Efficacy and Safety With Oral AZD9833 Compared With Intramuscular Fulvestrant in Post-menopausal Women at Least 18 Years of Age With Advanced ER-positive HER2 Negative Breast CancerNCT04214288 · 2020-04-22 · 1 site observation
ACTIVE_NOT_RECRUITING
An Extension Study of Ublituximab in Participants With Relapsing Multiple SclerosisNCT04130997 · 2019-11-18 · 1 site observation
ACTIVE_NOT_RECRUITING
Long-Term Outcomes and Durability of Effect Following Treatment With Cladribine Tablets for MS (CLASSIC-MS)NCT03961204 · 2019-08-15 · 1 site observation
COMPLETED
Avelumab Program Rollover StudyNCT03815643 · 2019-03-22 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study to Evaluate the Efficacy and Safety of Anamorelin HCl for the Treatment of Malignancy Associated Weight Loss and Anorexia in Adult Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) - 1NCT03743051 · 2019-03-05 · 1 site observation
COMPLETED
A Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for Treatment of Participants With Metastatic Prostate CancerNCT03748641 · 2019-01-25 · 1 site observation
ACTIVE_NOT_RECRUITING
Study of Durvalumab+Olaparib or Durvalumab After Treatment With Durvalumab and Chemotherapy in Patients With Lung Cancer (ORION)NCT03775486 · 2018-12-21 · 1 site observation
ACTIVE_NOT_RECRUITING
Efficacy and Safety Study of EG12014 Compared With Herceptin in Subjects With HER2 Positive Early Breast CancerNCT03433313 · 2018-10-16 · 1 site observation
COMPLETED
The Use of TrIple Fixed-dose Combination in the Treatment of Arterial HypertensionNCT03722524 · 2018-10-01 · 1 site observation
COMPLETED
A Study on the Control of Chronic Obstructive Pulmonary Disease (COPD) in Patients Taking the Combination of Tiotropium and Olodaterol Using the Respimat® InhalerNCT03663569 · 2018-08-15 · 2 site observations
COMPLETED
Trial to Compare the Safety, Efficacy and Immunogenicity of TX05 With Herceptin® in HER2+ Early Breast CancerNCT03556358 · 2018-06-28 · 1 site observation
COMPLETED
Study to Investigate CSL112 in Subjects With Acute Coronary SyndromeNCT03473223 · 2018-03-21 · 1 site observation
COMPLETED
Combinations of Cemiplimab (Anti-PD-1 Antibody) and Platinum-based Doublet Chemotherapy in Patients With Lung CancerNCT03409614 · 2018-03-06 · 1 site observation
COMPLETED
A Study Comparing MB02 and Avastin® in Subjects With Stage IIIB/IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC)NCT03296163 · 2018-02-06 · 1 site observation
COMPLETED
A Study of LY900014 in Participants With Type 1 DiabetesNCT03214367 · 2017-07-17 · 1 site observation
COMPLETED
A Study of LY900014 Compared to Insulin Lispro in Participants With Type 2 DiabetesNCT03214380 · 2017-07-14 · 1 site observation
COMPLETED
Long-term Extension to Study AC-058B301 to Investigate Safety, Tolerability and Disease Control of Ponesimod 20 mg in Patients With Relapsing Multiple SclerosisNCT03232073 · 2017-07-05 · 1 site observation
COMPLETED
Dinutuximab and Irinotecan Versus Irinotecan to Treat Subjects With Relapsed or Refractory Small Cell Lung CancerNCT03098030 · 2017-06-01 · 1 site observation
COMPLETED
Study of REGN 2810 Compared to Platinum-Based Chemotherapies in Participants With Metastatic Non-Small Cell Lung Cancer (NSCLC)NCT03088540 · 2017-05-29 · 1 site observation
COMPLETED
A Study Of Lorlatinib Versus Crizotinib In First Line Treatment Of Patients With ALK-Positive NSCLCNCT03052608 · 2017-04-27 · 1 site observation
ACTIVE_NOT_RECRUITING
MYL-1402O Compared With Avastin®, in Patients With Stage IV nsNSCLCNCT04633564 · 2017-01-21 · 1 site observation
COMPLETED
An Observational Study of Alogliptin Benzoate in Participants With Diabetes Mellitus Type 2NCT02756832 · 2016-09-20 · 1 site observation
COMPLETED
Evaluation of FKB238 and Avastin in Patients With Advanced/Recurrent Non-squamous Non-small Cell Lung CancerNCT02810457 · 2016-09-07 · 1 site observation
COMPLETED
Comparative Clinical Trial of Efficacy and Safety of BCD-055 and Remicade® in Combination With Methotrexate in Patients With Active Rheumatoid ArthritisNCT02762838 · 2016-01-01 · 1 site observation
COMPLETED
Avelumab in First-line NSCLC (JAVELIN Lung 100)NCT02576574 · 2015-10-29 · 1 site observation
COMPLETED
Efficacy and Safety of Finerenone in Subjects With Type 2 Diabetes Mellitus and Diabetic Kidney DiseaseNCT02540993 · 2015-09-17 · 1 site observation
COMPLETED
Efficacy and Safety of Finerenone in Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Kidney DiseaseNCT02545049 · 2015-09-17 · 1 site observation
COMPLETED
Phase III Trial BI 695502 Plus Chemotherapy vs. Avastin® Plus Chemotherapy in Patients With Lung CancerNCT02272413 · 2015-07-08 · 1 site observation
COMPLETED
A Study Of PF-06410293 (Adalimumab-Pfizer) And Adalimumab (Humira®) In Combination With Methotrexate In Subjects With Active Rheumatoid Arthritis (REFLECTIONS B538-02).NCT02480153 · 2015-06-25 · 1 site observation
COMPLETED
Oral Ponesimod Versus Teriflunomide In Relapsing MUltiple SclerosisNCT02425644 · 2015-06-04 · 1 site observation
COMPLETED
A Study of Atezolizumab Compared With Gemcitabine Plus (+) Cisplatin or Carboplatin for PD-L1-Selected Participants With Stage IV Squamous Non-Small Cell Lung Cancer (NSCLC) (IMpower111)NCT02409355 · 2015-05-07 · 1 site observation
TERMINATED
Observational Multicenter Non-interventional Study on COPD Patients Treatment Strategies at the Time of Hospital Discharge and Within 12 Months of Follow-up on an Outpatient Primary Care BasementNCT02346292 · 2015-03-31 · 1 site observation
COMPLETED
Study of Ozanimod (RPC1063) in Relapsing Multiple Sclerosis (MS)NCT02294058 · 2014-12-03 · 1 site observation
COMPLETED
An Efficacy and Safety Study of Apalutamide (JNJ-56021927) in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone in Participants With Chemotherapy-naive Metastatic Castration-resistant Prostate Cancer (mCRPC)NCT02257736 · 2014-11-26 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study of Abemaciclib (LY2835219) in Participants With Previously Treated KRAS Mutated Lung CancerNCT02152631 · 2014-10-03 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study Of PF-05280014 Or Trastuzumab Plus Taxotere® And Carboplatin In HER2 Positive Breast Cancer In The Neoadjuvant Setting (REFLECTIONS B327-04)NCT02187744 · 2014-09-23 · 1 site observation
COMPLETED
A Study of PF-06438179 (Infliximab-Pfizer) and Infliximab in Combination With Methotrexate in Subjects With Active Rheumatoid Arthritis (REFLECTIONS B537-02).NCT02222493 · 2014-08-26 · 1 site observation
COMPLETED
Efficacy and Safety Evaluating Study of CT-P6 in Her2 Positive Early Breast CancerNCT02162667 · 2014-06-01 · 1 site observation
COMPLETED
A Study Comparing Sirukumab (CNTO 136) Monotherapy With Adalimumab (HUMIRA®) Monotherapy in the Treatment of Active Rheumatoid ArthritisNCT02019472 · 2014-04-04 · 1 site observation
COMPLETED
Phase 3 Study of Bavituximab Plus Docetaxel Versus Docetaxel Alone in Patients With Late-stage Non-squamous Non-small-cell Lung CancerNCT01999673 · 2013-12-01 · 1 site observation
COMPLETED
Study to Investigate the Safety and Efficacy of Tregalizumab in Subjects (MTX-IR) With Active Rheumatoid ArthritisNCT01999192 · 2013-10-01 · 1 site observation
TERMINATED
Efficacy, Safety, and Tolerability of Plovamer Acetate (Pathway 1)NCT01963611 · 2013-10-01 · 1 site observation
TERMINATED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.